This week, hearings scheduled before the Supreme Court of Canada, Federal Court of Appeal, and Federal Court included matters ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Amgen's Wezlana leading ustekinumab biosimilar launches, potentially driving savings and access, as highlighted by Dracey ...

Piper Sandler analyst Christopher Raymond maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a price ...

Shares of satellite-services company ViaSat tanked early Tuesday. Shares were off 18% in early trading at $9.16, while the ...

Dividend stocks can be terrific investments. The best ones provide investors with passive income and upside potential. Over ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Amidst today's fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts ...

Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen Bio’s leadership believes that ...

Shares of Agilent Technologies Inc. A slid 1.05% to $143.69 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.67% to ...